Distalmotion hat dies direkt geteilt
Distalmotion (#LSIAlumni) has been granted De Novo approval by the FDA to market the Dexter Surgical Robot for adult inguinal hernia repair. The company is focused on developing a robotic platform for high-volume procedures and bringing the benefits of robotic-assisted surgery to outpatient settings where demand for cost-effective and efficient solutions continue to grow. With more than 1,300 patients successfully treated in Europe, Distalmotion’s extensive experience has paved the way for bringing this innovation to the U.S. market. Dexter integrates seamlessly into existing operating room workflows, is fully compatible with current OR equipment, and offers single-use instruments to simplify reprocessing. Its design provides direct and quick access to the patient, giving surgeons the flexibility to choose the optimal technique for each step of the procedure. Congratulations to LSI Alumni Greg Roche and the Distalmotion team on this major milestone! To hear more, check out Greg Roche’s full presentation from LSI USA '24 on our website and YouTube channel, and meet him this March at LSI USA '25, where he’s set to present the latest updates.